These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 2570429

  • 1. RBC and plasma choline in neuroleptic-treated schizophrenic patients.
    Lawson WB, Jeste DV, Hanin I, Kopp U, Wyatt RJ.
    Psychiatry Res; 1989 Jul; 29(1):45-53. PubMed ID: 2570429
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses].
    Dutoit D, Thomas P, Leroux JM, Vaiga G, Pommery J, Cottencin O, Erb F, Goudemand M.
    Encephale; 1995 Jul; 21(6):417-24. PubMed ID: 8674466
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Red blood cell membrane dynamics in schizophrenia. I. Membrane fluidity.
    Yao JK, van Kammen DP.
    Schizophr Res; 1994 Feb; 11(3):209-16. PubMed ID: 8193060
    [Abstract] [Full Text] [Related]

  • 6. Plasma amine metabolites before and after withdrawal from neuroleptic treatment in chronic schizophrenic inpatients.
    Kirch DG, Jaskiw G, Linnoila M, Weinberger DR, Wyatt RJ.
    Psychiatry Res; 1988 Sep; 25(3):233-42. PubMed ID: 2903509
    [Abstract] [Full Text] [Related]

  • 7. [Psychopathologic changes in chronic schizophrenic patients following withdrawal of neuroleptics: relation to therapeutic, neuroendocrine and computer tomography variables].
    Albus M, Naber D, Ackenheil M, Bürke H, Müller-Spahn F, Münch U, Reinertshofer T, Schmidt-Vanderheyden W, Weber G, Wissmann J.
    Fortschr Neurol Psychiatr; 1986 Jan; 54(1):15-20. PubMed ID: 2868983
    [Abstract] [Full Text] [Related]

  • 8. [Zotepine: treatment of schizophrenic patients with predominantly negative symptoms. A double-blind study vs. haloperidol].
    Barnas C, Stuppäck CH, Miller C, Haring C, Sperner-Unterweger B, Fleischhacker WW.
    Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():36-40. PubMed ID: 1683338
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Haloperidol and reduced haloperidol concentrations in plasma and red blood cells from chronic schizophrenic patients.
    Ko GN, Korpi ER, Kirch DG.
    J Clin Psychopharmacol; 1989 Jun; 9(3):186-90. PubMed ID: 2661607
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Red blood cell membrane dynamics in schizophrenia. III. Correlation of fatty acid abnormalities with clinical measures.
    Yao JK, van Kammen DP, Gurklis J.
    Schizophr Res; 1994 Oct; 13(3):227-32. PubMed ID: 7841135
    [Abstract] [Full Text] [Related]

  • 15. Neuroleptic effects on serine and glycine metabolism.
    Baruah S, Waziri R, Sherman A.
    Biol Psychiatry; 1993 Oct 15; 34(8):544-50. PubMed ID: 7903868
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. An open trial of buspirone added to neuroleptics in schizophrenic patients.
    Goff DC, Midha KK, Brotman AW, McCormick S, Waites M, Amico ET.
    J Clin Psychopharmacol; 1991 Jun 15; 11(3):193-7. PubMed ID: 2066458
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.